Stratagene, Harvard Bio, Bruker, Agilent, GE Healthcare, University of Hawaii Medical School, NIH, National Centers for Biomedical Computing, LBNL, UC Berkeley | GenomeWeb

Stratagene Posts Q4 Revenues Up 20 Percent

Stratagene reported that its revenues for the fourth quarter grew 20 percent to $22.8 million, compared with $18.9 million in the fourth quarter of 2003. The company said that $5.6 million was related to Stratagene's acquisition of Hycor in June 2004.

The La Jolla, Calif.-based company spent approximately $2.7 million on research and development in the fourth quarter of 2004, a slight increase from the approximately $2.3 million it spent on R&D in Q4 2003.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.